Nifedipine enhances the relaxant effects of cyclo-oxygenase inhibitors on the bovine ciliary muscle

Journal of Ocular Pharmacology and Therapeutics

Volumn 24, Issue 6, 2008, Pages 537-541

  Toker, Mustafa ^a   Bagcivan, Ihsan ^a   Topalkara, Aysen ^a   Karadas, Baris ^a   Durmus, Nedim ^a   Parlak, Ahmet ^a   Kaya, Tijen ^a  

^a CUMHURIYET UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

5,5, DIMETHYL 3 (3 FLUOROPHENYL) 4 (4 METHYLSULFONYL)PHENYL 2(5H) FURANONE; CALCIUM CHANNEL BLOCKING AGENT; CARBACHOL; CELECOXIB; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NIFEDIPINE; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLURRED VISION; CILIARY MOTILITY; CILIARY MUSCLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; COW; EYE PAIN; MUSCLE ISOMETRIC CONTRACTION; MUSCLE RELAXATION; NONHUMAN;

ANIMALS; CALCIUM CHANNEL BLOCKERS; CATTLE; CILIARY BODY; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FURANS; INDOMETHACIN; MUSCLE RELAXATION; NIFEDIPINE; PYRAZOLES; SULFONAMIDES;

EID: 57349153970     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2007.0129     Document Type: Article

References (23)

1. Delamere, N.A. Ciliary body and ciliary epithelium. Adv. Org. Biol. 10:127-148, 2005.
2. Goh, Y., Hoteyama, Y., and Mishima, H. Characterization of ciliary muscle relaxation induced by various agents in cats. Invest. Ophthalmol. Vis. Sci. 36:1188-1192, 1995.
3. van Alphen, G.W.H.M., Robinette, S.L., and Macri, F.J. Drug effects on ciliary muscle and choroid preparations in vitro. Arch. Ophthalmol. 68:111-123, 1962.
4. Cole, D.F., and Unger, W.G. Prostaglandins as mediators for the responses of the eye to trauma. Exp. Eye Res. 17:357-368, 1973.
5. Eakins, K.E. Prostaglandins and nonprostaglandin mediated breakdown of the blood-aqueous barrier. Exp. Eye Res. 25:483-498, 1977.
6. Rhi, A., Bhattacherjee, P., and Misra, R. Release of prostaglandins in experimental immunecomplex endophthalmitis and phacoallergic uveitis. Br. J. Ophthalmol. 62:105-109, 1978.
7. Bhattacherjee, P. The role of arachidonate metabolites in ocular inflammation. In: Bito, L.Z., Stjernchantz, J., eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss, 1989:211-227.
8. Bito, L.Z., Camras, C.B., Gum, G.G., et al. The ocular hypotensive effects and side-effects of prostaglandins on the eyes of experimental animals. In: Bito, L.Z., Stjernchantz, J., eds. The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss, 1989:349-368.
9. Camras, C.B., Bito, L.Z., and Eakins, K.E. Reduction of intraocular pressure by prostaglandins applied topically to the eye of conscious rabbits. Invest. Ophthalmol. Vis. Sci. 16:1125-1134, 1977.
10. Kaufman, P.L., and Crawford, K. Aqueous humor dynamics: How PGF2a lowers intraocular pressure. In: Bito, L.Z., Stjernchantz, J. (eds.). The Ocular Effects of Prostaglandins and Other Eicosanoids. New York: Alan R. Liss, 1989:387-416.
11. Jumblatt, M., and Paterson, C.A. PGE2 effects on corneal endothelial cyclic AMP synthesis and cell shape are mediated by a receptor of the EP2-subtype. Invest. Ophthalmol. Vis. Sci. 32:360-365, 1991.
12. Protzman, C.E., and Woodward, D.F. Prostanoid-induced blood-aqueous barrier breakdown in rabbits involves the EP2 receptor subtype. Invest. Ophthalmol. Vis. Sci. 31:2463-2466, 1990.
13. Ohia, S.E., and Jumblatt, J.E. Prejunctional inhibitory effects of prostanoids on sympathetic neurotransmission in the rabbit iris-ciliary body. J. Pharmacol. Exp. Ther. 255:11-16, 1990.
14. Bhattacherjee, P., Csukas, S., and Paterson, C.A. Prostaglandin E2 binding sites in bovine iris-ciliary body. Invest. Ophthalmol. Vis. Sci. 31:1109-1113, 1990.
15. Burke, A., Smyth, E., and FitzGerald, G.A. Analgesic-antipyretic agents: Pharmacotherapy of gout. In: Goodman & Gilman's The Pharmacological Bass Of Therapeutics, 11th ed. 2006. New York: McGraw-Hill.
16. Rasmussen, H. The calcium messenger system. N. Engl. J. Med. 314:1094-1101, 1986.
17. Weinreb, R.N., Kim, D.M., and Lindsey, J.D. Propagation of ciliary smooth muscle cells in vitro and effects of prostaglandin F2 alpha on calcium efflux. Invest. Ophthalmol. Vis. Sci. 33:2679-2686, 1992.
18. Fukuo, K., Morimoto, S., Koh, E., et al. Effects of prostaglandins on the cytosolic free-calcium concentration in vascular smooth muscle cells. Biochem. Biophys. Res. Commun. 136:247-252, 1986.
19. Molnar, M., Asem, E.K., and Hertelendy, F. Differential effects of prostaglandin F2 alpha and of prostaglandins E1 and E2 on cyclic 3′,5′-monophosphate production and intracellular calcium mobilization in avian uterine smooth muscle cells. Biol. Reprod. 36:384-391, 1987.
20. Takai, Y., Sugawara, R., Ohinata, H., et al. Two types of non-selective cation channel opened by muscarinic stimulation with carbachol in bovine ciliary muscle cells. J. Physiol. 559:899-922, 2004.
21. Lepple-Wienhues, A., Stahl, F., Willner, U., et al. Endothelin-evoked contractions in bovine ciliary muscle and trabecular meshwork: Interaction with calcium, nifedipine, and nickel. Curr. Eye Res. 10:983-989, 1991.
22. + channels are not involved in the regulation of bovine ciliary muscle contractility. J. Ocul. Pharmacol. Ther. 11:553-563, 1995.
23. Kamikawatoko, S., Tokoro, T., Azuma, H., et al. The effects of endothelin-1 on isolated bovine ciliary muscles. Exp. Eye Res. 61:559-564, 1995.